MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. - Wikidata - wikimedia - TriplyDB

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

http://www.wikidata.org/entity/Q36035692

about

Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia MLH1 methylation screening is effective in identifying epimutation carriers A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers.Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer.Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.Epigenetic mechanisms in the pathogenesis of Lynch syndrome.Colorectal serrated pathway cancers and precursors.Mismatch repair deficiency testing in clinical practice.Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer.Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations.Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.Epigenetics and Precision Oncology.EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.[Molecular pathology of colorectal cancer].

P2860

Q30587310-C64262CA-4D06-4E79-B099-36C23FE073AA Q33750060-27E1A76A-7A62-4A68-95D7-31B7E29E0ACE Q35063442-45F92DB8-842D-4E29-81DD-55B0F2F0D67B Q36375623-74B1345D-8828-4249-81AE-CE5A0384A4C2 Q36403949-5A7DB40E-9CDB-4343-A7DB-DF966082E97F Q36541715-6C84CA93-7547-4EDC-A998-832F531A19AA Q36896061-65C1426A-4243-4534-BAEF-B32C58286FFE Q37709387-069353D0-0308-4451-9ECD-90D98093211E Q38123671-A5D108EF-4B30-4F8E-BB72-CBE605F7D13F Q38180152-DE54D53B-72A3-4815-A864-1EBA0FFB86AE Q38255029-A07E52F1-9C00-4822-B478-84D5608FF7C0 Q38741029-F91413D7-8087-4EB7-9A77-C563B4493F1C Q40174495-66A53F2D-0E19-44BA-A3AB-7838B9465B8E Q42175718-7F233189-D8D8-4D53-9335-A39FA01F22C6 Q44756934-3BA2AB50-B5F1-4053-A5A0-19A7AE8416EF Q47109110-F4E7A571-00D9-4C63-B4DF-772D21A1D6BA Q48130104-1B60F67C-F607-451A-82D4-7D9074CF0470 Q48615237-20CB954E-2FF6-4F31-9632-050E93BB4714 Q50020927-926502A4-17E1-46D3-B405-1029EBE106C3 Q50877915-E386EC06-E923-49DF-9246-0375F29ED387 Q53081522-4F87F3E3-0331-4E30-BA70-ED701A74CBE0 Q53581884-6845A2FD-45F5-4316-BA21-3C3F2F609E47

P2860

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

http://www.wikidata.org/entity/Q36035692

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@ast

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@en

type

label

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@ast

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@en

prefLabel

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@ast

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@en

P1433

Q36035692-8F4E73A3-191D-4A21-80FD-AD8A9088C9C9

P1476

Q36035692-87E796DA-2AA3-49F2-9443-E1E0FA4276D8

P2093

Q36035692-44C40AE7-3995-4C74-A94E-E0965ABA2718

Q36035692-55C561C0-967A-478E-ADFC-93DC5272AFAD

Q36035692-5F4E0BCE-1F13-4139-B797-BB7042E7806A

Q36035692-71875535-E8DF-443B-BAC4-6310F6F0CBCA

Q36035692-867D0026-6105-4C50-88C5-FC4F627F3B1D

Q36035692-8D782022-9FC2-438F-A3AF-54A203722C7A

Q36035692-A7A8D8E0-E5C5-4B7F-80BB-CEC0E175D1CE

Q36035692-E3385ECE-5AC0-4E6E-AB84-1AEC84AD9D2D

Q36035692-F2B5080B-F50B-4B8A-A197-8CF6C54F42D9

Q36035692-F8D080AC-E360-4BCD-8269-9129E2E6A2AE

P2860

Q36035692-190CA2EB-285F-4930-81AA-A35F107C5FB8

Q36035692-22D72D2F-87FF-4281-8531-F793EBA47A67

Q36035692-274F19C9-1629-4838-B7E6-116F96723763

Q36035692-3D64386E-4986-449B-8A68-92D221283CB0

Q36035692-4401C1CA-1A4C-48DD-812F-F9B7A95A50BF

Q36035692-4CFD3BC0-E77B-4898-8169-6D29B359F207

Q36035692-5CA45663-6804-4B77-B80B-23EB070A3FBC

Q36035692-6C4C0EC4-41E6-4828-BABB-E47A4A691FA4

Q36035692-7AFDE2D6-231E-48B0-84C0-AFB10407D8D3

Q36035692-7CE42E00-0845-4DD7-8AA4-7D6CDE864423

P2888

Q36035692-57670A76-11F0-405F-8A77-3036CAF385E4

P304

Q36035692-19C98AC1-5301-474E-BCA0-F919C69002A3

P31

Q36035692-5E979138-8771-4213-960F-BD362B15DE6E

P356

Q36035692-74AFA0CB-43FC-4E70-A062-D4367758DFA7

P433

Q36035692-D492F0D2-9D14-430E-9B11-0144ABF6E2F9

P478

Q36035692-C578DCF9-C572-4FED-8C26-A9DE1DF07C06

P50

Q36035692-2B5AF4EF-4E50-4181-B71B-1F8213079D3E

Q36035692-93CBD900-9DC7-42B1-B9C7-AB0A1D72012C

Q36035692-E3CEB6C6-1BCC-492D-9714-4A87EC30412A

Q36035692-EF786DC2-20E2-4172-A0D7-42A7DB886035

P577

Q36035692-435EA6B7-038E-48D6-8C5D-978E485478C8

P5875

Q36035692-A48E89D5-4EFD-4CD1-8F36-CFFB36D794B6

P6179

Q36035692-5C97A472-945F-4FEE-9EDD-44718C07E836

P698

Q36035692-C82D7024-77A9-4DF4-BA16-95AE0E473E8D

P932

Q36035692-C5E523E4-CFEF-4C69-ABC9-410A0B5BDDA1

P356

P1433

European Journal of Human Genetics

P1476

MLH1 promoter hypermethylation ...... e: a cost-effectiveness study.

@en

P2093

Conxi Lázaro

http://www.w3.org/2001/XMLSchema#string

Gabriel Capellá

http://www.w3.org/2001/XMLSchema#string

Josep Alfons Espinàs

http://www.w3.org/2001/XMLSchema#string

Julieta Corral

http://www.w3.org/2001/XMLSchema#string

Llúcia Benito

http://www.w3.org/2001/XMLSchema#string

María Dolores Iniesta

http://www.w3.org/2001/XMLSchema#string

Mireia Gausachs

http://www.w3.org/2001/XMLSchema#string

Mireia Menéndez

http://www.w3.org/2001/XMLSchema#string

Pilar Mur

http://www.w3.org/2001/XMLSchema#string

Stephen B Gruber

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications

Smoking, gender, and ethnicity predict somatic BRAF mutations in colorectal cancer.

Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.

A role for MLH3 in hereditary nonpolyposis colorectal cancer.

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Cancer family "G" revisited: 1895-1970.

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum

Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers

P2888

P304

762-768

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EJHG.2011.277

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221774838

http://www.w3.org/2001/XMLSchema#string

P6179

1019904160

http://www.w3.org/2001/XMLSchema#string

P698

22274583

http://www.w3.org/2001/XMLSchema#string

P932

3376264

http://www.w3.org/2001/XMLSchema#string